Live News REGULATION L impact Jul 16, 2026, 08:30 PM UTC

VNDA Vanda Pharmaceuticals - imsidolimab BLA for gpp under FDA review with target action date December 12, 2026

VNDA Vanda Pharmaceuticals - imsidolimab BLA for gpp under FDA review with target action date December 12, 2026

SquawkNews Newsroom

VNDA Vanda Pharmaceuticals - imsidolimab BLA for gpp under FDA review with target action date December 12, 2026